Taking a page out of big pharma’s marketing playbook, Myriad Genetics this week launched a direct-to-consumer television advertising campaign aimed to educate women about the risk of inherited breast and ovarian cancer associated with BRCA1 and BRCA2 genetic mutations, and simultaneously, advertise its BRACAnalysis test.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.